Hypothesis

Core idea: Prelamin A accumulation at the nuclear lamina not only traps CK2α kinase but also prevents its phosphorylation of LEM2, a lamina‑associated protein that regulates ATM‑dependent detachment of lamina‑associated domains (LADs) during DNA double‑strand break (DSB) repair. When LEM2 remains hypophosphorylated, LADs stay tethered to the periphery, delaying repair, increasing chromatin extrusion through nuclear blebs, and elevating genomic instability. This model integrates the CK2α sequestration mechanism with the ATM‑dependent LAD remodeling pathway and offers a direct, testable link between lamina composition and DDR efficiency.

Mechanistic rationale

1. CK2α‑LEM2 axis: CK2α phosphorylates LEM2 on serine/threonine residues within its nucleoplasmic domain, reducing LEM2’s affinity for chromatin and promoting its release from the nuclear envelope. Phosphorylated LEM2 facilitates the mechanical uncoupling of LADs needed for ATM signaling to spread and for repair factors to access DSBs within heterochromatin.

2. Effect of prelamin A: Farnesylated prelamin A forms a stable scaffold that sequesters CK2α at the lamina, lowering its local kinase activity toward LEM2. Consequently, LEM2 stays hypophosphorylated, maintaining strong LAD–lamina interactions.

3. Consequences for DSB repair: In heterochromatin (LADs), DSBs require ATM‑triggered nuclear envelope remodeling and LAD detachment. Persistent LAD tethering slows ATM autophosphorylation, delays 53BP1/BRCA1 recruitment, and favors chromatin extrusion through nuclear blebs—a phenotype observed in HGPS and aged cells.

4. Integration with R‑loop pathway: Impaired LAD detachment also prolongs transcriptional silencing at the periphery, potentially increasing R‑loop formation when transcription escapes repression, thereby linking lamina defects to the second pathway described by FG‑nucleoporin loss.

Testable predictions

• Prediction 1: In primary human fibroblasts expressing induced prelamin A (via doxycycline‑inducible construct), LEM2 phosphorylation at CK2 consensus sites (e.g., SxxS) will be significantly reduced after ionizing radiation compared with control cells.
• Prediction 2: Pharmacological activation of CK2 (e.g., low‑dose spermidine or a CK2 agonist) will restore LEM2 phosphorylation, promote LAD detachment (measured by DamID or Lamin B1 ChIP‑seq), and decrease γH2AX foci persistence in heterochromatin.
• Prediction 3: Expression of a phosphomimetic LEM2 mutant (S→D) in prelamin A‑expressing cells will rescue DSB repair kinetics in LADs, reducing chromatin extrusion and senescence markers (p16^INK4a^, SA‑β‑gal) without altering prelamin A levels.
• Prediction 4: Conversely, a phospho‑dead LEM2 mutant (S→A) will phenocopy prelamin A effects in wild‑type cells, causing delayed LAD detachment and increased genomic instability even when CK2 is active.
• Prediction 5: Farnesyltransferase inhibitors (FTIs) will decrease prelamin A lamina accumulation, increase CK2α availability, elevate LEM2 phosphorylation, and improve DSB repair in LADs across multiple cell types (fibroblasts, iPSC‑derived mesenchymal stem cells, and neurons).

Experimental approach

• Use CRISPR‑edited HEK293 or iPSC lines to inducible express prelin A or wild‑type lamin A.
• Measure LEM2 phosphorylation by phospho‑specific antibodies or mass spectrometry after IR (2 Gy).
• Assess LAD detachment using DamID‑seq for Lamin B1 or lamin A/C ChIP‑seq before and after damage.
• Quantify DSB repair in heterochromatin via γH2AX/53BP1 foci co‑localization with H3K9me3 domains and using neutral comet assays.
• Evaluate downstream phenotypes: nuclear bleb frequency, RNA‑FISH for retained transcripts, R‑loop detection (S9.6 assay), and senescence markers.
• Validate in aged human tissue samples (e.g., skin biopsies) correlating prelamin A levels, LEM2 phosphorylation status, and markers of genomic instability.

Potential impact

If confirmed, this hypothesis positions the lamina as a dynamic signaling hub where its composition directly tunes kinase substrates that govern chromatin mobility during DNA repair. It bridges two major lamina‑genomic instability pathways—CK2α‑mediated DDR attenuation and ATM‑dependent LAD remodeling—offering a unified therapeutic angle: boosting CK2 activity or mimicking LEM2 phosphorylation could mitigate age‑related genome instability without altering lamin expression levels.